Daily supplementation with vitamin D3, calcium did not significantly reduce the risk of recurrent adenomas.
Risk of colorectal adenoma recurrence up for men with low recreation activity, high sedentary time.
Mutations in four genes never before associated with colorectal cancer have been found to raise a person's risk for the disease by up to 40%.
A recent study uncovered adenoma detection rates significantly higher than those set in national guidelines.
People with Lynch syndrome who eat a lot of snack foods were twice as likely as others with this condition to develop colorectal adenomas.
A 2-hour course designed to increase clinicians' adenoma detection rate (ADR) made a big difference, even for experienced endoscopists.
It may be reasonable to use methods other than colonoscopy to rescreen people who had negative results on their first screening colonoscopy.
Two of three main recommendations for colonoscopy surveillance are now supported by stronger evidence than they were in 2006.
Dividing bowel preparation solution into two doses resulted in better preparation quality, detection rates, and colonoscopy completion rates.
Characteristics of the colonoscopy rather than those of the adenomas removed may be the most significant determinants of colorectal cancer risk.
For patients with multiple colorectal adenomas, prevalence of APC, MUTYH mutations varies.
Significant risk reduction within 5 years for both genders, all ages, those with high-risk polyps.
CT colonography can accurately detect adenomas 10 mm or larger in patients who did not undergo laxative-induced bowel cleansing before the procedure.
CT colonography accurately detects cancer and precancerous polyps in persons aged 65 years and older.
Provocative evidence indicates that daily aspirin at doses of 75 mg and above might lower overall cancer incidence and overall cancer mortality.
Researchers at Seidman Cancer Center in Cleveland are recruiting patients for a study of a new, noninvasive technology for colon cancer screening.
Adenomas and high-risk lesions were frequently detected on repeat colonoscopy, suggesting the lesions were missed on initial colonoscopy.
And, more adenomatous polyps identified with colonoscopy than fecal immunochemical testing.
Offering CT colonography improved participation in colorectal cancer screening by more than 50% compared with colonoscopy, but colonoscopy identified significantly more advanced neoplasia.
Although colorecetal cancer screening rose from 52% in 2002 to 65% in 2010, that still leaves approximately one-third of adults untested, says a new report from the CDC.
Abnormally dense blood vessel growth in the mouth may signal familial adenomatous polyposis, which causes colorectal adenomas in teens and progresses to cancer if colectomy is not done.
A study makes a case for targeting colorectal cancer screening in older adults so that those who will benefit do get tested, and those who won't benefit aren't exposed to unnecessary burdens.
A simple system of letters and telephone calls using electronic medical records significantly improved adherence to endoscopic follow-up recommendations among persons due for a colonoscopy examination.
Identifying families at risk improves screening and counseling of patients at risk for hereditary nonpolyposis colorectal cancer.
Shorter duration of sleep significantly increased a person's risk of developing colorectal adenomas—a finding that suggests sleep duration as a novel risk factor for colorectal neoplasia.
Aspirin is effective for secondary prevention of colorectal adenoma, according to the results of a meta-analysis.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|